Enoxaparin (low molecular weight heparin) prevents catheter-related venous thrombosis after infant cardiac surgery

This issue of 2022 presents a paper on prevention of catheter-related venous thrombosis after infant cardiac surgery.

Central venous catheter (CVC)-related venous thrombosis after cardiac surgery in infants with congenital heart disease is considered a serious problem. Although there are currently no established methods to prevent the risk of postoperative thrombosis, we present here a paper that may provide a possible countermeasure.

If you would like to read further, please join our mailing list or read the NOTE.

NOTE

Enoxaparin (low molecular weight heparin) prevents catheter-related venous thrombosis after infant cardiac surgery Central venous catheter (CVC)-related venous thrombosis following cardiac surgery in infants with congenital heart disease is a serious problem. When a central vein is occluded by a thrombus, circulation due to stasis of blood flow...